Immy

IMMY was founded in 1979 with a particular focus in mycology, or the study of fungi. At that time, mycology was virtually a forgotten area in the clinical laboratory, and there was a definite need for diagnostic products to detect fungal infections. Since that time, IMMY has evolved from a company that filled a need in the market to an organization with a global focus on saving lives through affordable diagnostics. Our work and efforts are still devoted to manufacturing high-quality fungal diagnostics, but the scope and reach of the product line has broadened immensely. Many of our recent endeavors have centered on improving diagnostics for the developing world. Areas such as sub-Saharan Africa lack the necessary infrastructure to provide patients with adequate healthcare. However, we can help alleviate this problem by delivering diagnostics that can be performed without complex laboratory equipment or even the basic necessities, like electricity or running water. We take pride in producing reliable, accurate diagnostics, that bridge the gap between a sick patient and the treatment they desperately need. We have been able to play a critical role in raising the standard of healthcare for patients all over the world.